Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity

被引:16
作者
Celie, PHN
Lenting, PJ
Mertens, K
机构
[1] CLB, Dept Plasma Prot Technol, NL-1066 CX Amsterdam, Netherlands
[2] Univ Utrecht, UIPS, Dept Pharmaceut, NL-3584 CA Utrecht, Netherlands
关键词
D O I
10.1074/jbc.275.1.229
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The three-dimensional structure of activated factor IX comprises multiple contacts between the two epidermal growth factor (EGF)-like domains. One of these is a salt bridge between Glu(78) and Arg(94), which is essential for binding of factor Ma to its cofactor factor VIII and for factor VIII-dependent factor X activation (Christophe, O. D., Lenting, P. J., Kolkman, J. A. Brownlee, G. G., and Mertens, K. (1998) J. Biol. Chem. 273, 222-227). We now addressed the putative hydrophobic contact at the interface between the EGF-like domains, Recombinant factor IX chimeras were constructed in which hydrophobic regions Phe(75)-Phe(77) and Lys(106)-Val(108) were replaced by the corresponding sites of factor X and factor VII, Activated factor IX/factor X chimeras were indistinguishable from normal factor Ma with respect to factor Ma enzymatic activity. In contrast, factor IXa(75-77)/factor VII displayed similar to 2-fold increased factor X activation in the presence of factor VIII, suggesting that residues 75-77 contribute to cofactor-dependent factor X activation. Activation of factor X by factor IX106-108/factor VII was strongly decreased, both in the absence and presence of factor VIII. Activity could be restored by simultaneous substitution of the hydrophobic sites in both EGF-like domains for factor VII residues. These data suggest that factor Ma enzymatic activity requires hydrophobic contact between the two EGF-like domains.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 40 条
[1]  
AHMAD SS, 1992, J BIOL CHEM, V267, P8571
[2]  
AJAJ SP, 1999, THROMB HAEMOSTASIS, V82, P218
[3]   The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor [J].
Banner, DW ;
DArcy, A ;
Chene, C ;
Winkler, FK ;
Guha, A ;
Konigsberg, WH ;
Nemerson, Y ;
Kirchhofer, D .
NATURE, 1996, 380 (6569) :41-46
[4]  
Bode W, 1997, THROMB HAEMOSTASIS, V78, P501
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   X-RAY STRUCTURE OF CLOTTING FACTOR IXA - ACTIVE-SITE AND MODULE STRUCTURE RELATED TO XASE ACTIVITY AND HEMOPHILIA-B [J].
BRANDSTETTER, H ;
BAUER, M ;
HUBER, R ;
LOLLAR, P ;
BODE, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9796-9800
[7]   X-ray structure of active site-inhibited clotting factor Xa - Implications for drug design and substrate recognition [J].
Brandstetter, H ;
Kuhne, A ;
Bode, W ;
Huber, R ;
vonderSaal, W ;
Wirthensohn, K ;
Engh, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :29988-29992
[8]   Substitution of Arg(527) and Arg(531) in factor VIII associated with mild haemophilia A: characterization in terms of subunit interaction and cofactor function [J].
Celie, PHN ;
van Stempvoort, G ;
Jorieux, S ;
Mazurier, C ;
van Mourik, JA ;
Mertens, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) :792-800
[9]   Replacing the first epidermal growth factor-like domain of Factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B [J].
Chang, JY ;
Monroe, DM ;
Stafford, DW ;
Brinkhous, KM ;
Roberts, HR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (04) :886-892
[10]   Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain [J].
Christophe, OD ;
Lenting, PJ ;
Kolkman, JA ;
Brownlee, GG ;
Mertens, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :222-227